We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Femeda is a UK based healthcare company focused on the development an innovative female health portfolio.
With its specialism in female health, it has recently launched its first product Pelviva, a treatment for female urinary incontinence in the UK. Pelviva is a new and unique disposable, clinically effective, discreet and easy-to-use Pelvic Floor muscle re-trainer which treats urinary incontinence in women, demonstrating proven clinical success.
Pelviva addresses THE biggest unmet need in female health. The unique development is the result of combining advanced research and patents from University of Manchester with Femeda product development expertise to deliver a product which meets core patient needs.
A third of all women suffer from bladder leakage and Pelviva is the first product of its kind that is really easy to use and is clinically proven to treat bladder leaks. Pelviva is a pioneering medical device that will have a life-changing impact on women’s quality of life.